Congratulations to our diligent and talented team members who are taking on larger roles as we develop our novel technologies to cure atherosclerosis!
- Dr. Daniel Clemens: Vice President of Biology
- Dr. Keivan Sadrerafi: Director of Chemistry
- Dr. Prerna Bhargava: Senior Scientist
- Darren Dinh: Senior Research Associate/ Lab Manager
It is through the hard work of our dedicated team that we are able to take on the world’s leading killer!
About Cyclarity
Cyclarity Therapeutics, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting oxidized cholesterol using rationally designed molecules, to provide the first true disease-modifying treatments for common age-related conditions such as atherosclerosis, heart attack and stroke. Its products are based on novel derivatives of a well-known, safe compound and a new way of looking at cardiovascular disease. For more information, please visit www.cyclaritytx.com or send an email to press@cyclaritytx.com
Contact:
Mike Kope
CEO of Corporate Affairs
Cyclarity Therapeutics, Inc.
press@cyclaritytx.com
